The Indonesian health sector is currently experiencing a financing transition that will have a profound impact on the country's efforts to achieve universal health coverage (UHC) and national health goals. The transition is marked, on the one hand, by increasing per capita expenditure on health and, on the other, by declining of out-of-pocket payments (OOP) and a significant reduction of external funding for health as a source of health financing. Assuming steady economic growth, Indonesia is soon projected to greatly reduce or transition from its reliance on external financing for the national AIDS, Tuberculosis (TB), Malaria, and Childhood Immunization (ATMI) programs. While varying somewhat from program to program, the extent of financial transition required will be substantial for all four programs. Complicating the transition process is the fact that all four programs are currently engaged in making significant changes in program strategies and implementation processes in response to both underperformance and Indonesia's commitment to reaching global targets.